We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Determines Xarelto Trial Results Not Affected by Faulty Device
FDA Determines Xarelto Trial Results Not Affected by Faulty Device
The FDA has determined that the results of the Xarelto clinical trial were not affected by a faulty monitoring device used in the trial, and that the drug’s approval will stand.